Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Paul R. Gater"'
Publikováno v:
The Journal of Immunology. 166:1233-1240
Ag-specific activation of CD4+ T cells is known to be causative for the cytokine production associated with lung allergy. Chemokine-induced leukocyte recruitment potentially represents a critical early event in Ag-induced lung inflammation. Whether A
Publikováno v:
American Journal of Respiratory and Critical Care Medicine. 161:1340-1348
CD4(+) T cells are thought to play a major role in the initiation and perpetuation of T helper cell, type 2 (Th2)-like allergic airway inflammation. However, it is not clear whether activation of resident antigen-specific CD4(+) T cells is in itself
Publikováno v:
European Journal of Pharmacology. 304:123-128
Endothelin exerts a variety of biological effects in the lung which indicate that this peptide may have a role in the pathophysiology of a number of pulmonary diseases. In this study, the endothelin receptors on the human bronchus were compared with
Publikováno v:
American Journal of Respiratory Cell and Molecular Biology. 14:454-460
Tumor necrosis factor (TNF) is an inflammatory cytokine produced by many cell types which may contribute to the pathophysiology of a variety of lung diseases. In this study we have used Ro 45-2081 (a soluble receptor composed of the human p55 TNF rec
Autor:
Michael Brewster, Peter M. Paciorek, John F. Waterfall, Jennifer C. McKean, Kevin L. Wilson, Paul R. Gater
Publikováno v:
European Journal of Pharmacology. 238:59-64
This study compares the effects of two K(+0-channel openers, Ro 31-6930 and BRL 38227, on cholinergically-evoked contraction of guinea-pig airways to examine whether either compound acts through prejunctional inhibition of the release of acetylcholin
Autor:
Fabien Schmidlin, Patrick G. Knott, David Lewis, Paul R. Gater, Silvia Amadesi, Karim Dabbagh, Pierangelo Geppetti, Claude Bertrand, Nigel W. Bunnett, Mary E. Stevens
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 169(9)
Trypsin and mast cell tryptase can signal to epithelial cells, myocytes, and nerve fibers of the respiratory tract by cleaving proteinase-activated receptor 2 (PAR2). Since tryptase inhibitors are under development to treat asthma, a precise understa